Skip to main content
. 2012 Jul;60(7):502–511. doi: 10.1369/0022155412447296

Table 1.

Primary antibody and conditions used

Antibody Conditions Used
Ki67 (clone MIB-1; Dakocytomation, Heverlee, Belgium) Undiluted, 20 min
VDR (sc-13133; Santa Cruz Biotechnology, Heidelberg, Germany) 1/500, 20 min
CYP24A1 (sc-32166; Santa Cruz Biotechnology) 1/20, 20 min
CYP27B1 (kind gift of Dr. R. Bland, University of Warwick, Coventry, UK) 1/500, overnight